Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Metastatic Castrate-Resistant Prostate Cancer · mCRPC (Metastatic Castration-resistant Prostate Cancer)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cancer Hosipital of Shandong First Medical University,440 Jiyan Road, Jinan City, Shandong Province, Jinan, Shandong, China
Contact: Principal Investigator (Jiasheng Bian)270 Dongan Road, Shanghai, Shanghai, Shanghai Municipality, China
Contact: Principal Investigator (Dingwei Ye)
Study leads
D Ye, M.D.
Principal Investigator
Dingwei Ye